Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 June 2024
| m 04:03 | Nivolumab (Opdivo) diffhist +210 Jwarner talk contribs →Malignant pleural mesothelioma | ||||
| m 03:50 | Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →Renal cell carcinoma | ||||
|
|
m 03:26 | Stub 2 changes history +16,468 [Jwarner (2×)] | |||
| m |
|
03:26 (cur | prev) +504 Jwarner talk contribs →Regimens that contain experimental (unapproved) drugs | |||
| m |
|
03:25 (cur | prev) +15,964 Jwarner talk contribs →Regimens composed solely of approved drugs | |||
20 May 2024
| m 13:28 | Study Groups diffhist -1 Jwarner talk contribs →Main table | ||||
17 May 2024
15 May 2024
13 May 2024
| m 13:39 | Study Groups diffhist +4 Jwarner talk contribs →Main table | ||||
6 May 2024
|
|
m 23:34 | Gastric cancer, HER2-positive 2 changes history +5 [Warner-admin (2×)] | |||
| m |
|
23:34 (cur | prev) +4 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1434" | |||
| m |
|
23:34 (cur | prev) +1 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1433" | |||
| m 23:34 | Esophageal cancer diffhist +1 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1433" | ||||